101. Azemiopsin from Azemiops feae Viper Venom, a Novel Polypeptide Ligand of Nicotinic Acetylcholine Receptor
- Author
-
Vladislav G. Starkov, Sarah C. R. Lummis, Ngoc Anh Hoang, Daniel Bertrand, Andrew J. Thompson, Werner Sieghart, Igor E. Kasheverov, T. V. Andreeva, Maxim N. Zhmak, Joachim Ramerstorfer, Yuri N. Utkin, Elena V. Kryukova, Victor I. Tsetlin, and Christoph Weise
- Subjects
Neurotransmitter Transport ,Male ,Nicotinic Acetylcholine Receptors ,Molecular Sequence Data ,Radioreceptor Assays ,Venom ,Peptide ,Viper Venoms ,Receptors, Nicotinic ,Ligands ,complex mixtures ,Biochemistry ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,Peptide synthesis ,Toxins ,Animals ,Amino Acid Sequence ,Molecular Biology ,Peptide sequence ,Chromatography, High Pressure Liquid ,030304 developmental biology ,Cys-loop Receptors ,chemistry.chemical_classification ,Mice, Inbred BALB C ,0303 health sciences ,Sequence Homology, Amino Acid ,Edman degradation ,Circular Dichroism ,Snake Venom ,030302 biochemistry & molecular biology ,Cell Biology ,3. Good health ,Nicotinic acetylcholine receptor ,chemistry ,Snake venom ,Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ,Protein Structure and Folding ,Azemiops feae ,Neurotoxin ,Peptides ,Cys-loop receptors - Abstract
Background: Venoms from rare snake species may contain toxins of new structural or/and pharmacological types. Results: Amino acid sequence of the new polypeptide azemiopsin isolated from Azemiops feae viper venom was established, and its biological activity was determined. Conclusion: Azemiopsin is the first natural toxin that blocks nicotinic acetylcholine receptors and does not contain disulfide bridges. Significance: Azemiopsin is the first member of a new toxin group., Azemiopsin, a novel polypeptide, was isolated from the Azemiops feae viper venom by combination of gel filtration and reverse-phase HPLC. Its amino acid sequence (DNWWPKPPHQGPRPPRPRPKP) was determined by means of Edman degradation and mass spectrometry. It consists of 21 residues and, unlike similar venom isolates, does not contain cysteine residues. According to circular dichroism measurements, this peptide adopts a β-structure. Peptide synthesis was used to verify the determined sequence and to prepare peptide in sufficient amounts to study its biological activity. Azemiopsin efficiently competed with α-bungarotoxin for binding to Torpedo nicotinic acetylcholine receptor (nAChR) (IC50 0.18 ± 0.03 μm) and with lower efficiency to human α7 nAChR (IC50 22 ± 2 μm). It dose-dependently blocked acetylcholine-induced currents in Xenopus oocytes heterologously expressing human muscle-type nAChR and was more potent against the adult form (α1β1ϵδ) than the fetal form (α1β1γδ), EC50 being 0.44 ± 0.1 μm and 1.56 ± 0.37 μm, respectively. The peptide had no effect on GABAA (α1β3γ2 or α2β3γ2) receptors at a concentration up to 100 μm or on 5-HT3 receptors at a concentration up to 10 μm. Ala scanning showed that amino acid residues at positions 3–6, 8–11, and 13–14 are essential for binding to Torpedo nAChR. In biological activity azemiopsin resembles waglerin, a disulfide-containing peptide from the Tropidechis wagleri venom, shares with it a homologous C-terminal hexapeptide, but is the first natural toxin that blocks nAChRs and does not possess disulfide bridges.
- Published
- 2012
- Full Text
- View/download PDF